Itell H, Humes D, Overbaugh J
Cell Rep. 2023; 42(6):112556.
PMID: 37227817
PMC: 10592456.
DOI: 10.1016/j.celrep.2023.112556.
Itell H, Humes D, Overbaugh J
bioRxiv. 2023; .
PMID: 36798236
PMC: 9934674.
DOI: 10.1101/2023.02.07.527545.
Phetsouphanh C, Phalora P, Hackstein C, Thornhill J, Munier C, Meyerowitz J
Elife. 2021; 10.
PMID: 34951583
PMC: 8752121.
DOI: 10.7554/eLife.50324.
Morvan M, Teque F, Locher C, Levy J
Microbiol Mol Biol Rev. 2021; 85(2).
PMID: 33980586
PMC: 8139528.
DOI: 10.1128/MMBR.00155-20.
Thames A, Irwin M, Breen E, Cole S
Psychoneuroendocrinology. 2019; 106:277-283.
PMID: 31029930
PMC: 6589103.
DOI: 10.1016/j.psyneuen.2019.04.016.
Immunogenicity and Efficacy of a Novel Multi-Antigenic Peptide Vaccine Based on Cross-Reactivity between Feline and Human Immunodeficiency Viruses.
Sahay B, Aranyos A, Mishra M, McAvoy A, Martin M, Pu R
Viruses. 2019; 11(2).
PMID: 30717485
PMC: 6409633.
DOI: 10.3390/v11020136.
Lessons Learned in Developing a Commercial FIV Vaccine: The Immunity Required for an Effective HIV-1 Vaccine.
Sahay B, Yamamoto J
Viruses. 2018; 10(5).
PMID: 29789450
PMC: 5977270.
DOI: 10.3390/v10050277.
Type I interferon and HIV: Subtle balance between antiviral activity, immunopathogenesis and the microbiome.
Scagnolari C, Antonelli G
Cytokine Growth Factor Rev. 2018; 40:19-31.
PMID: 29576284
PMC: 7108411.
DOI: 10.1016/j.cytogfr.2018.03.003.
Complex Interplay between HIV-1 Capsid and MX2-Independent Alpha Interferon-Induced Antiviral Factors.
Bulli L, Apolonia L, Kutzner J, Pollpeter D, Goujon C, Herold N
J Virol. 2016; 90(16):7469-7480.
PMID: 27279606
PMC: 4984639.
DOI: 10.1128/JVI.00458-16.
Constitutively Active MAVS Inhibits HIV-1 Replication via Type I Interferon Secretion and Induction of HIV-1 Restriction Factors.
Gupta S, Termini J, Issac B, Guirado E, Stone G
PLoS One. 2016; 11(2):e0148929.
PMID: 26849062
PMC: 4743994.
DOI: 10.1371/journal.pone.0148929.
Differential Specificity of Interferon-alpha Inducible Gene Expression in Association with Human Immunodeficiency Virus and Hepatitis C Virus Levels and Declines .
Katsounas A, Frank A, Lempicki R, Polis M, Asmuth D, Kottilil S
J AIDS Clin Res. 2015; 6(1).
PMID: 26052470
PMC: 4456029.
DOI: 10.4172/2155-6113.1000410.
Conserved epitopes on HIV-1, FIV and SIV p24 proteins are recognized by HIV-1 infected subjects.
Roff S, Sanou M, Rathore M, Levy J, Yamamoto J
Hum Vaccin Immunother. 2015; 11(6):1540-56.
PMID: 25844718
PMC: 4514358.
DOI: 10.1080/21645515.2015.1026500.
Predicting the impact of CD8+ T cell polyfunctionality on HIV disease progression.
Graw F, Regoes R
J Virol. 2014; 88(17):10134-45.
PMID: 24965450
PMC: 4136339.
DOI: 10.1128/JVI.00647-14.
Immune responses during spontaneous control of HIV and AIDS: what is the hope for a cure?.
Saez-Cirion A, Jacquelin B, Barre-Sinoussi F, Muller-Trutwin M
Philos Trans R Soc Lond B Biol Sci. 2014; 369(1645):20130436.
PMID: 24821922
PMC: 4024229.
DOI: 10.1098/rstb.2013.0436.
The Significance of Interferon-γ in HIV-1 Pathogenesis, Therapy, and Prophylaxis.
Roff S, Noon-Song E, Yamamoto J
Front Immunol. 2014; 4:498.
PMID: 24454311
PMC: 3888948.
DOI: 10.3389/fimmu.2013.00498.
Feline immunodeficiency virus envelope glycoproteins antagonize tetherin through a distinctive mechanism that requires virion incorporation.
Morrison J, Guevara R, Marcano A, Saenz D, Fadel H, Rogstad D
J Virol. 2014; 88(6):3255-72.
PMID: 24390322
PMC: 3957917.
DOI: 10.1128/JVI.03814-13.
Relative resistance of HIV-1 founder viruses to control by interferon-alpha.
Fenton-May A, Dibben O, Emmerich T, Ding H, Pfafferott K, Aasa-Chapman M
Retrovirology. 2013; 10:146.
PMID: 24299076
PMC: 3907080.
DOI: 10.1186/1742-4690-10-146.
Can non-lytic CD8+ T cells drive HIV-1 escape?.
Seich Al Basatena N, Chatzimichalis K, Graw F, Frost S, Regoes R, Asquith B
PLoS Pathog. 2013; 9(11):e1003656.
PMID: 24244151
PMC: 3828169.
DOI: 10.1371/journal.ppat.1003656.
Innate immune evasion strategies by human immunodeficiency virus type 1.
Guha D, Ayyavoo V
ISRN AIDS. 2013; 2013:954806.
PMID: 24052891
PMC: 3767209.
DOI: 10.1155/2013/954806.
CD8(+) lymphocytes suppress human immunodeficiency virus 1 replication by secreting type I interferons.
Killian M, Teque F, Walker R, Meltzer P, Killian J
J Interferon Cytokine Res. 2013; 33(11):632-45.
PMID: 23402527
PMC: 3814821.
DOI: 10.1089/jir.2012.0067.